Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Ann Surg Oncol. 2015 Sep 4;23(2):471–476. doi: 10.1245/s10434-015-4841-4

TABLE 4.

Oncotype scores among those with discordant risk-group scores

graphic file with name nihms-730734-t0001.jpg
Oncotype DX
Recurrence Score
Predicted 10yr
Risk of Recurrence, %
Risk Group Recommended
Treatment Change
13
22
8
14
Low
Intermediate
No
2
34
4
23
Low
High
Yes
32
24
21
15
High
Intermediate
No
18 and 8
10
8
7
Intermediate
Low
Yes
35
13
24
8
High
Low
No
3
19
4
12
Low
Intermediate
No
11
22
7
14
Low
Intermediate
Yes
20
0
13
3
Intermediate
high
yes
13
19
9 Low
Intermediate
Yes
21
12
14
8
Intermediate
Low
Yes
18
11
11
7
Intermediate
Low
Yes
19
4
12
4
Intermediate
Low
Yes
19
10
12
7
Intermediate
Low
No
18
12
12
8
Intermediate
Low
No